Difficulty: Medium
Average Score: 85%
Practice
Which one of the following can be blocked by atropine?
Correct answer
D
Rationale
Atropine is a competitive antagonist of acetylcholine at muscarinic receptors, meaning it blocks the effects of acetylcholine on these receptors. In the given options, the correct answer is D) Tachycardia caused by infusion of acetylcholine. Atropine blocks the parasympathetic effects of acetylcholine, leading to an increase in heart rate (tachycardia) by inhibiting the vagus nerve.
Option A) Decreased blood pressure caused by hexamethonium is incorrect because hexamethonium is a ganglionic blocker that acts on nicotinic receptors in the autonomic ganglia, not muscarinic receptors affected by atropine.
Option B) Increased blood pressure caused by nicotine is incorrect because nicotine acts on nicotinic receptors, not muscarinic receptors like atropine.
Option C) Increased skeletal muscle strength caused by neostigmine is incorrect because neostigmine is an acetylcholinesterase inhibitor that increases the levels of acetylcholine at neuromuscular junctions, enhancing muscle contractions, which is unrelated to atropine's mechanism of action.
Understanding the effects of atropine on the peripheral nervous system is crucial in pharmacology and clinical practice. By grasping how atropine blocks certain responses mediated by acetylcholine, healthcare professionals can effectively manage conditions such as bradycardia or organophosphate poisoning. This knowledge is valuable in emergency situations and in various medical specialties, including anesthesiology and cardiology.
Option A) Decreased blood pressure caused by hexamethonium is incorrect because hexamethonium is a ganglionic blocker that acts on nicotinic receptors in the autonomic ganglia, not muscarinic receptors affected by atropine.
Option B) Increased blood pressure caused by nicotine is incorrect because nicotine acts on nicotinic receptors, not muscarinic receptors like atropine.
Option C) Increased skeletal muscle strength caused by neostigmine is incorrect because neostigmine is an acetylcholinesterase inhibitor that increases the levels of acetylcholine at neuromuscular junctions, enhancing muscle contractions, which is unrelated to atropine's mechanism of action.
Understanding the effects of atropine on the peripheral nervous system is crucial in pharmacology and clinical practice. By grasping how atropine blocks certain responses mediated by acetylcholine, healthcare professionals can effectively manage conditions such as bradycardia or organophosphate poisoning. This knowledge is valuable in emergency situations and in various medical specialties, including anesthesiology and cardiology.